Skip to content

Clinical trials

Phase 2 Blepharitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blepharitis Phase: Phase 2 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20093
20102
20141
20191
20201
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Nicox Ophthalmics, Inc.2
Tarsus Pharmaceuticals, Inc.2
Alcon Research1
Aperta Biosciences, LLC1
Federal University of São Paulo1
Galderma R&D1
Kala Pharmaceuticals, Inc.1
Laboratoires Thea1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blepharitis13
Meibomian Gland Dysfunction3
Corneal Diseases1
Dry Eye Syndromes1
Inflammation1
Meibomitis1
Mite Infestations1
Pain1

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.